Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Female Patients

The purpose of this study was to investigate differences in risk prediction in female post-infarction patients.

Completed

Looking for future studies?

Key information

Conditions

Myocardial Infarction Behavior Cardiovascular Diseases Coitus Heart Diseases Infarction Ischemia Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Sexual Behavior Vascular Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

1. Medizinische Klinik, Klinikum rechts der Isar, Munich, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

acute myocardial infarction; female gender

Exclusion criteria

Sponsors and collaborators

Lead sponsor

Deutsches Herzzentrum Muenchen

Other

Registry information

Important dates

Study start: 1995
First posted: Sep 20, 2005
Registry last updated: Mar 12, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed